pSivida Limited expressly disclaims any obligation to review, update or correct these materials after the date thereof. pSivida Limited may update, amend, supplement or otherwise alter the information contained in any such materials by subsequent presentations, reports, filings, or other mean without notice.

The information on this website does not constitute a solicitation or offer relating to any securities of pSivida Limited or its subsidiaries. Past financial, operating and share price performance of pSivida Limited cannot be relied upon as a guide to future financial, operating and share price performance.

All statements in the Site that are not historical, are “forward-loo king statements” within the meaning of Section 21E of the U.S. Securities Exchange Act of 1934, as amended including statements regarding pSivida's “expectations,” “potential”, “ beliefs,” “hopes,” “intentions,” “strategies,” or the like. Such statements are subject to risks and uncertainties that could cause actual results to differ materially for pSivida from those projected, including, but not limited to, risks of our ability to achieve and sustain higher levels of revenue, gross margins, reduced operating expenses, uncertainties relating to technological approaches, product development, manufacturing, market acceptance, personnel retention, uncertainties related to cost and pricing of pSivida products, dependence on collaborative partners, uncertainties relating to sole source suppliers, uncertainties relating to FDA and other regulatory approvals, competition, risks relating to intellectual property of others and the uncertainties of patent protection and litigation. pSivida undertakes no obligation to update such forward-loo king statements. These and other risk factors are discussed in greater details in pSivida's U.S. securities filings available on the U.S. Securities exchange Commission's website ( www.sec.gov ). pSivida Limited assumes no obligation and does not intent to update these forward-loo king statements.